04:13 PM EDT, 06/03/2024 (MT Newswires) -- Samuel Bates Martin, Senior Vice President and CFO, on May 30, 2024, sold 35,000 shares in Celldex Therapeutics ( CLDX ) for $1,191,775. Following the Form 4 filing with the SEC, Martin has control over a total of 25,128 shares of the company, with 25,128 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/744218/000141588924015147/xslF345X03/form4-06032024_080645.xml

Price: 34.00, Change: +0.53, Percent Change: +1.58